ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,038.40
-2.10%
다우존스 지수
43,428.02
-1.69%
Bitcoin
96,334.37
0.20%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) 시세

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
3.65
0.0962
(2.71%)
마감 22 2월 6:00AM
15분 지연
4.20
0.55
(15.07%)
시간외 거래: 9:57AM
15분 지연

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

주요 통계 및 세부정보

가격
4.20
매수가
3.00
매도가
4.25
거래량
57,084
3.53 일간 변동폭 3.75
2.20 52주 범위 4.20
market_cap
149.615M
전일 종가
3.5538
개장가
3.59
최근 거래 시간
197
@
4.2
(formt)
마지막 거래 시간
재정 규모
US$ 205,468
VWAP
3.5994
평균 볼륨(3m)
10,462
발행 주식
35,622,553
배당수익률
-
주가수익률
-6.66
주당순이익(EPS)
-0.79
매출
-
순이익
-28.22M

Eupraxia Pharmaceuticals Inc 정보

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
www.eupraxiapharma.com
본부
Victoria, British Columbia, Can
설립됨
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was US$3.55. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of US$ 2.20 to US$ 4.20.

Eupraxia Pharmaceuticals currently has 35,622,553 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is US$126.60 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.66.

EPRX 최신 뉴스

추가 뉴스

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
18 2월 2025
EPRX (2.71%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
20 11월 2024
EPRX (2.71%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
15 11월 2024
EPRX (2.71%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
14 11월 2024
EPRX (2.71%)

Form D - Notice of Exempt Offering of Securities
Edgar (US Regulatory)
09 11월 2024
EPRX (2.71%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.0432.91139240513.164.23.09276853.37940659CS
41.1537.70491803283.054.22.845135833.25012184CS
120.616.66666666673.64.22.75104623.22580776CS
261.4954.98154981552.714.22.2125323.14820361CS
520.6518.30985915493.554.22.2153112.97283946CS
1560.6518.30985915493.554.22.2153112.97283946CS
2600.6518.30985915493.554.22.2153112.97283946CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?
The current share price of Eupraxia Pharmaceuticals is US$ 4.20
How many Eupraxia Pharmaceuticals shares are in issue?
Eupraxia Pharmaceuticals has 35,622,553 shares in issue
What is the market cap of Eupraxia Pharmaceuticals?
The market capitalisation of Eupraxia Pharmaceuticals is USD 126.6M
What is the 1 year trading range for Eupraxia Pharmaceuticals share price?
Eupraxia Pharmaceuticals has traded in the range of US$ 2.20 to US$ 4.20 during the past year
What is the PE ratio of Eupraxia Pharmaceuticals?
The price to earnings ratio of Eupraxia Pharmaceuticals is -6.66
What is the reporting currency for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals reports financial results in USD
What is the latest annual profit for Eupraxia Pharmaceuticals?
The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M
What is the registered address of Eupraxia Pharmaceuticals?
The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.
What is the Eupraxia Pharmaceuticals website address?
The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com
Which industry sector does Eupraxia Pharmaceuticals operate in?
Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.44k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.75M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
FLDFold Holdings Inc
US$ 6.95
(-37.39%)
488.54k
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.14M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

토론

전체 피드 보기
Homebrew Homebrew 3 분 전
Name calling and insults won't save QSEP.
QSEP
3331 3331 4 분 전
BIEL: Ready to launch in New Zealand!!!
https://www.actipatch.nz/
DiscoverGold DiscoverGold 5 분 전
Cocoa plunges more than 11%, its 5th largest decline in history
By: Barchart | February 21, 2025

• Cocoa plunges more than 11%, its 5th largest decline in history.

pbs.twimg.com/media/GkV8a1xXgAAfvcg?format=jpg&name=large

https://x.com/Barc
weedtrader420 weedtrader420 5 분 전
BITCOIN XRP 🥊😁🥊 keep your hands up. I need a lift then a right
BTCUSD
SilkRoad SilkRoad 6 분 전
Laugh it up fuzzball.
https://www.youtube.com/watch?v=jPLFvGaRAas

In response to:

“LOL”

and in further response to:

“The team continues to produce recombinant spider silk, taking only the time necessary between cycles to sterilize Kr
KBLB
3331 3331 6 분 전
BIEL: Ready to launch in New Zealand!!!
https://www.actipatch.nz/
CK-verse CK-verse 8 분 전
$HHSE: Social Media Ads Launch THIS WEEKEND with Theatre Chains, FaceBook and Instagram for UNHOLY SONG
Friday, February 21, 2025



https://hannoverhousemovies.blogspot.com/2025/02/social-media-ads-launch-this-weekend.html



Greetings
HHSE
zerosnoop zerosnoop 8 분 전
The latest PR below seems to have the paid bashers, naked short sellers & uneducated fools with a low IQ panicking big time. If authorities don't believe lying grubs , nor do I

https://ir.qsenergy.com/news/press-releases/detail/2063/made-in-america-built-for-the-world-qs-energy-moves-
QSEP
3331 3331 10 분 전
BIEL: HUGE VA NEWS - Flagship product RecoveryRX now available to all veterans at all VA's!
Ted Fienning
BioElectronics Corporation
Harvard University
Marine Corp Pilot
"Share with any veteran you know using the VA: RecoveryRX is an FDA-approved pain management dev
3331 3331 11 분 전
BIEL: HUGE VA NEWS - Flagship product RecoveryRX now available to all veterans at all VA's!
Ted Fienning
BioElectronics Corporation
Harvard University
Marine Corp Pilot
"Share with any veteran you know using the VA: RecoveryRX is an FDA-approved pain management dev
pos_stock_hoarder pos_stock_hoarder 14 분 전
Perfect!
manibiotech manibiotech 14 분 전
Maybe someone with more experience can chime in. If the oncologist wants to give patient DcvAx and Keytruda separately by his choice . What can prevent that physician from doing so as he is free to prescribe either treatment separately ??
NWBO
weedtrader420 weedtrader420 15 분 전
Crypto power is changing hands. It’s going from the left hand to the right.✊😎☝️ the left is selling everything Trump likes. probably a little bit more torture that’s OK. will make us stronger.
BTCUSD
janice shell janice shell 15 분 전
Yes, we will. But that kind of thing is impossible to keep quiet.
BDEZ BDEZ 18 분 전
Elon: Every bleeding-heart liberal I talk to about the Russia-Ukraine war wants to keep feeding bodies into the meat grinder forever.

They have no plan for success.

Superficial empathy, not real empathy.
attilathehunt attilathehunt 18 분 전
style="caret-color: rgb(29, 38, 46); color: rgba(29, 38, 46, 1); font-family: DMSans-Regular, sans-serif; font-size: 18.525px"✅ If NWBO’s combination patent is enforced, it could protect Keytruda’s sales by blocking biosimilars from copying the combo.
style="caret-color: rgb(29, 38, 4
NWBO
WinstonCup WinstonCup 19 분 전
Agree!
WDLF
WinstonCup WinstonCup 20 분 전
Your just as pathetic as old cowboy and inspector gadget!
WDLF
zerosnoop zerosnoop 21 분 전
The below is so TRUE in regards to QSEP

A stock basher is someone who manipulates the market to cause a drop in asset prices.

Stock bashers disseminate misinformation in the hopes that investors will believe the false claims and sell their stock before the price drops.
QSEP
BDEZ BDEZ 22 분 전
What harm could Gazan children possibly pose to Britain’s national security?”

https://x.com/EdgeE50124/status/1892868482405994980
3331 3331 22 분 전
BIEL: HUGE HIT IN TAIWAN!
https://www.actipatchtw.com/general-1

최근 히스토리

NASDAQ
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지